About Aurora Research Institute
An Aurora Diagnostics Company
Who is ARI?
The Aurora Research Institute (ARI) is a subsidiary of Aurora Diagnostics, the largest Anatomic Pathology company in North America.
Aurora Diagnostics is the result of $400+ million in investment and 11+ years of effort to bring together the best-in-class Pathologists in the United States. This national network of Professional Medical Investigators, combined with a staff of trained Clinical Research Coordinators can be accessed through ARI. This greatly accelerates research initiatives by providing ethically collected human biospecimens, leveraging the expertise and services of 31+ specialty laboratories employing 800+ medical technicians, and providing access to 140+ hospitals and 200+ sub-specialized Pathologists.
What We Do?
The Aurora Research Institute (ARI) provides customizable research services to Global BioPharma and IVD Companies.
This allows companies to accelerate their research and development projects in this new era of personalized medicine and diagnostics.
The process begins at the pre-clinical development phase, before the diagnostic product enters into FDA monitored clinical trials. Early collaborations between pharmaceutical companies, diagnostic manufacturers, and ARI will result in faster regulatory submissions and approvals.
The Aurora Research Institute, combined with Aurora Diagnostics, together possess the nationwide biomaterial network, pathology expertise, laboratory capabilities, project management services, and national sales force to help your company propel new products from discovery to market.
Why Choose Aurora Research Institute?
ARI performs IRB-approved research protocols in CAP-accredited and CLIA-certified full-service pathology and molecular, independent, free-standing and hospital-based laboratories.
Our parent company, Aurora Diagnostics, employees 200+ board certified pathologists and operates 32+ laboratories in the United States which currently service 140+ community-based hospitals and 15,000 referring physicians.
Our laboratories process more than 9,000+ patient samples per day making Aurora Diagnostics the largest independent pathology company in the United States. Our CFR-Part 11 compliant laboratory information system (LIS) allows for enhanced data mining and analytic capabilities as well as digital pathology review and consultation. The groundbreaking technology combined with our staff of board-certified pathologists and scientists enables centralized pathology review by sub-specialized pathologists in support of your research.
ARI’s mission is to support the global drug discovery and diagnostics research community to advance precision medicine by providing access to high-quality biospecimens, expert consultative Pathology services, molecular laboratory services, and a national network of laboratories and hospitals. Our clinical research services will accelerate laboratory validation studies, drug discovery efforts and biomarker research to advance personalized medicine.
To create a global network of laboratories and medical providers that meet the needs of researchers and accelerate discovery in the quest to cure disease.
Aurora Diagnostics voluntarily filed financial reports with the SEC beginning in 2011 and continuing through May 2017, in accordance SEC guidelines for public companies. We continue to follow Generally Accepted Accounting Principles, or GAAP, to provide transparency to bondholders and investors. Aurora has successfully completed multiple FDA audits at our internal research facilities. All of our tests are developed and validated in full compliance with all appropriate federal, state and local laws, rules and regulations. The standards we adhere to include those set by CLIA, by the state of New York, and CAP standards. We require all clinical laboratory personnel to have appropriate credentials and experience to perform the tests provided by Aurora. Finally, all personnel are required to participate in continuing educational training and competency programs.
The quality we provide our clients is based upon ensuring the adherence to the highest ethical standards, patient care, and research protocols and to deliver our services in a way that consistently meets expectations and requirements.
Our unwavering commitment to conduct medical and business practices with the highest ethical standards, respect for others, and as responsible members of our locally supported communities is clearly recognized by our clients, patients, and employees.
We recognize that we are here to serve others. And the best way to serve is through understanding our clients’ and patients’ needs and holding ourselves accountable to satisfying those needs with compassion and excellence.
With our collective knowledge and our passion for learning, we are dedicated to creating and nurturing an environment of professional development and continuous improvement.
We encourage ourselves to take responsibility and to be proactive in the identification, recommendation, and execution of improvements in the delivery of products and services to our clients for the creation of unsurpassed research and discovery.